The Legalization of Cannabis in Germany: A Step Forward in Drug Policy
Germany has recently distinguished itself in the European landscape by embarking on a significant path toward the controlled legalization of cannabis for recreational purposes. This move represents a substantial change in the country's drug policy, projecting it toward a more progressive and public health-oriented approach. However, while Germany embraces change, Italy continues to find itself trapped in prohibitionism, with significant consequences for society and public health.
The Legalization of Cannabis in Germany: A Holistic Approach
Germany's decision to legalize cannabis for recreational purposes was driven by a series of factors, including growing public support, scientific research on the safety and impacts of cannabis, and the need to reduce crime related to the black market for drugs. The new law, enacted in 2023, allows the sale and consumption of cannabis for recreational purposes by adults over the age of 18.
The approach adopted by Germany reflects a commitment to harm reduction and product quality control.
Cannabis will only be sold through authorized stores, with strict controls on quality and labeling. In addition, the law provides for public education on responsible consumption and the prevention of abuse.
This move has been met with broad consensus within German society, with many seeing the legalization of cannabis as a step toward a more humane and effective drug policy. The new legal cannabis industry is expected to create new jobs and generate significant tax revenues for the government, which could be reinvested in prevention and addiction treatment programs.
Prohibitionism in Italy: A Persistent Challenge
While Germany embraces legalization, Italy continues to maintain a strongly prohibitionist approach toward cannabis. Despite growing public support for a review of drug policy, the Italian government has so far hesitated to take significant steps toward legalization.
Prohibitionism in Italy has contributed to a series of social and health problems. The black market for cannabis thrives, fueling organized crime and violence. In addition, the lack of regulation means that consumers do not have access to reliable information about the quality and composition of the products they purchase, increasing the risk to public health.
Italy could draw inspiration from Germany's approach and from other countries that have adopted more progressive cannabis policies. A review of drug policy could lead to a reduction in cannabis-related crime, better protection of public health, and more efficient use of government resources.
In conclusion, the legalization of cannabis in Germany represents a significant step toward a more humane and effective drug policy. While Germany embraces change, Italy continues to struggle with a prohibitionist approach that has proven inadequate in responding to current challenges related to cannabis. It is time for Italy to carefully examine its own drug policy and consider a more progressive and public health-oriented approach

